250 related articles for article (PubMed ID: 11447330)
1. Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor.
Horschitz S; Hummerich R; Schloss P
Neuroreport; 2001 Jul; 12(10):2181-4. PubMed ID: 11447330
[TBL] [Abstract][Full Text] [Related]
2. Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1.
Sur C; Betz H; Schloss P
J Neurochem; 1998 Jun; 70(6):2545-53. PubMed ID: 9603221
[TBL] [Abstract][Full Text] [Related]
3. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice.
Monaca C; Boutrel B; Hen R; Hamon M; Adrien J
Neuropsychopharmacology; 2003 May; 28(5):850-6. PubMed ID: 12637954
[TBL] [Abstract][Full Text] [Related]
4. Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter.
Horschitz S; Hummerich R; Schloss P
Biochem Soc Trans; 2001 Nov; 29(Pt 6):728-32. PubMed ID: 11709064
[TBL] [Abstract][Full Text] [Related]
5. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.
Benmansour S; Owens WA; Cecchi M; Morilak DA; Frazer A
J Neurosci; 2002 Aug; 22(15):6766-72. PubMed ID: 12151556
[TBL] [Abstract][Full Text] [Related]
6. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?
Goulet M; Miller GM; Bendor J; Liu S; Meltzer PC; Madras BK
Synapse; 2001 Dec; 42(3):129-40. PubMed ID: 11746710
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
Ravna AW; Sylte I; Dahl SG
J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
[TBL] [Abstract][Full Text] [Related]
8. Efflux studies allow further characterisation of the noradrenaline and 5-hydroxytryptamine transporters in rat lungs.
James KM; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):126-33. PubMed ID: 9228199
[TBL] [Abstract][Full Text] [Related]
9. High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions.
Plenge P; Wiborg O
Neurosci Lett; 2005 Aug; 383(3):203-8. PubMed ID: 15955412
[TBL] [Abstract][Full Text] [Related]
10. Monitoring mouse serotonin transporter internalization in stem cell-derived serotonergic neurons by confocal laser scanning microscopy.
Lau T; Horschitz S; Bartsch D; Schloss P
Neurochem Int; 2009; 54(3-4):271-6. PubMed ID: 19121357
[TBL] [Abstract][Full Text] [Related]
11. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
[TBL] [Abstract][Full Text] [Related]
12. Effects of corticosterone ingestion on hippocampal [(3)H]serotonin reuptake in inbred rat strains.
Fernandez F; Coomans V; Mormede P; Chaouloff F
Endocr Regul; 2001 Sep; 35(3):119-26. PubMed ID: 11674840
[TBL] [Abstract][Full Text] [Related]
13. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
14. Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter.
Scholze P; Zwach J; Kattinger A; Pifl C; Singer EA; Sitte HH
J Pharmacol Exp Ther; 2000 Jun; 293(3):870-8. PubMed ID: 10869387
[TBL] [Abstract][Full Text] [Related]
15. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
Davids E; Zhang K; Kula NS; Tarazi FI; Baldessarini RJ
J Pharmacol Exp Ther; 2002 Jun; 301(3):1097-102. PubMed ID: 12023542
[TBL] [Abstract][Full Text] [Related]
16. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques.
Lu NZ; Eshleman AJ; Janowsky A; Bethea CL
Mol Psychiatry; 2003 Mar; 8(3):353-60. PubMed ID: 12660809
[TBL] [Abstract][Full Text] [Related]
17. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
[TBL] [Abstract][Full Text] [Related]
18. Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons.
Kittler K; Lau T; Schloss P
Eur J Pharmacol; 2010 Mar; 629(1-3):63-7. PubMed ID: 20006597
[TBL] [Abstract][Full Text] [Related]
19. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
Chen F; Larsen MB; Sánchez C; Wiborg O
Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
[TBL] [Abstract][Full Text] [Related]
20. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
